| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-5793(99)01400-3 |
| P698 | PubMed publication ID | 10556527 |
| P2093 | author name string | Y Xu | |
| G Hong | |||
| L M Baudhuin | |||
| P2860 | cites work | Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 | Q24314828 |
| Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival | Q36256204 | ||
| Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness | Q37249572 | ||
| Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells | Q40607042 | ||
| Cadherins as determinants of tissue morphology and suppressors of invasion. | Q40641262 | ||
| Cadherins in cancer: implications for invasion and metastasis | Q40780329 | ||
| Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways | Q40867323 | ||
| Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling | Q41024128 | ||
| Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells | Q42814183 | ||
| Lysophospholipids activate ovarian and breast cancer cells | Q42821442 | ||
| Survival by Mac-1-mediated adherence and anoikis in phorbol ester-treated HL-60 cells | Q47982503 | ||
| Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin | Q71472642 | ||
| Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride | Q71597850 | ||
| Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis | Q71695241 | ||
| Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product | Q71857863 | ||
| Sphingosine-1-phosphate inhibits extracellular matrix protein-induced haptotactic motility but not adhesion of B16 mouse melanoma cells | Q72271109 | ||
| Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum | Q73436742 | ||
| Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes | Q74105987 | ||
| Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells | Q74424236 | ||
| Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers | Q77204834 | ||
| P433 | issue | 3 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 513-518 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells | |
| P478 | volume | 460 |
| Q41661043 | "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer. |
| Q92345266 | A novel tool for suspension culture of human induced pluripotent stem cells: Lysophospholipids as a cell aggregation regulator |
| Q40837836 | An oncogenic role of sphingosine kinase |
| Q34197851 | Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640 |
| Q33183333 | Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density |
| Q30300375 | Decreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1. |
| Q36169377 | Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila. |
| Q39714109 | Effect of S1P5 on proliferation and migration of human esophageal cancer cells |
| Q33197889 | Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle |
| Q39646488 | Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity |
| Q28187730 | Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer |
| Q24300944 | Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P |
| Q35853199 | Insights into the pharmacological relevance of lysophospholipid receptors |
| Q91713219 | LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer |
| Q37727151 | Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat |
| Q34233431 | Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. |
| Q39458550 | Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models |
| Q89481733 | Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment |
| Q33829692 | Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget |
| Q36953297 | Metabolic changes during ovarian cancer progression as targets for sphingosine treatment. |
| Q57146844 | Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model |
| Q38871513 | MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1. |
| Q41490261 | Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells |
| Q35146936 | Pleiotropic actions of sphingosine-1-phosphate |
| Q33649759 | Regulation of cytoskeleton organization by sphingosine in a mouse cell model of progressive ovarian cancer |
| Q37699403 | S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. |
| Q80222028 | S1P regulation of ovarian carcinoma invasiveness |
| Q44612302 | Sphingosine 1-phosphate and cell migration: resistance to angiogenesis inhibitors |
| Q36890026 | Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor |
| Q40271531 | Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells |
| Q34126142 | Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors |
| Q40142808 | Sphingosine 1-phosphate triggers apoptotic signal for B16 melanoma cells via ERK and caspase activation |
| Q34233389 | Sphingosine 1-phosphate: synthesis and release |
| Q53623000 | Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. |
| Q37192698 | Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight |
| Q36835075 | Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways |
| Q89162813 | Survival benefit of sphingosin-1-phosphate and receptors expressions in breast cancer patients |
| Q37172893 | Targeting SphK1 as a new strategy against cancer |
| Q36970728 | Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression |
| Q39169603 | The Unique Molecular and Cellular Microenvironment of Ovarian Cancer |
| Q36101228 | Toward an integrative analysis of the tumor microenvironment in ovarian epithelial carcinoma |
Search more.